Bayrak Ebt Taban Stock Current Valuation
| BAYRK Stock | TRY 17.91 0.03 0.17% |
Valuation analysis of Bayrak EBT Taban helps investors to measure Bayrak EBT's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Bayrak EBT's price fluctuation is not too volatile at this time. Calculation of the real value of Bayrak EBT Taban is based on 3 months time horizon. Increasing Bayrak EBT's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bayrak EBT is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayrak Stock. However, Bayrak EBT's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.91 | Real 15.23 | Hype 17.91 | Naive 17.45 |
The intrinsic value of Bayrak EBT's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bayrak EBT's stock price.
Estimating the potential upside or downside of Bayrak EBT Taban helps investors to forecast how Bayrak stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayrak EBT more accurately as focusing exclusively on Bayrak EBT's fundamentals will not take into account other important factors: Bayrak EBT Taban Company Current Valuation Analysis
Bayrak EBT's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bayrak EBT Current Valuation | 227.89 M |
Most of Bayrak EBT's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayrak EBT Taban is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bayrak EBT Taban has a Current Valuation of 227.89 M. This is 98.74% lower than that of the Consumer Cyclical sector and 99.9% lower than that of the Footwear & Accessories industry. The current valuation for all Turkey stocks is 98.63% higher than that of the company.
Bayrak Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayrak EBT's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bayrak EBT could also be used in its relative valuation, which is a method of valuing Bayrak EBT by comparing valuation metrics of similar companies.Bayrak EBT is rated below average in current valuation category among its peers.
Bayrak Fundamentals
| Return On Equity | 6.37 | |||
| Return On Asset | 4.72 | |||
| Profit Margin | 6.17 % | |||
| Operating Margin | 11.50 % | |||
| Current Valuation | 227.89 M | |||
| Shares Outstanding | 23.56 M | |||
| Shares Owned By Insiders | 45.20 % | |||
| Price To Earning | 55.68 X | |||
| Price To Book | 3.29 X | |||
| Price To Sales | 3.32 X | |||
| Revenue | 54.85 M | |||
| Gross Profit | 9.85 M | |||
| EBITDA | 9.21 M | |||
| Net Income | 3.39 M | |||
| Cash And Equivalents | 11.2 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 29.16 M | |||
| Debt To Equity | 0.53 % | |||
| Current Ratio | 1.78 X | |||
| Book Value Per Share | 2.35 X | |||
| Cash Flow From Operations | (7.33 M) | |||
| Earnings Per Share | 0.14 X | |||
| Number Of Employees | 280 | |||
| Market Capitalization | 182.37 M | |||
| Z Score | 3.6 |
About Bayrak EBT Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayrak EBT Taban's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayrak EBT using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayrak EBT Taban based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bayrak Stock
Bayrak EBT financial ratios help investors to determine whether Bayrak Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayrak with respect to the benefits of owning Bayrak EBT security.